Related Experiment Videos
Glycosylated haemoglobin levels in children with diabetes mellitus
Insights
Glycosylated hemoglobin (HbA1) offers an objective measure for assessing long-term blood glucose control in diabetic children. This method shows a stronger correlation with growth parameters than traditional tests, highlighting its potential for monitoring diabetes management.
Area of Science:
- Pediatric Endocrinology
- Clinical Chemistry
- Diabetes Mellitus Research
Background:
- Effective monitoring of blood glucose control is crucial for managing diabetes in children.
- Traditional methods for assessing glycemic control, such as home urine glucose testing and 24-hour urine glucose excretion, have limitations in accuracy and objectivity.
- Growth parameters, like height velocity, can be influenced by the long-term metabolic state in diabetic children.
Purpose of the Study:
- To evaluate the utility of total glycosylated hemoglobin (HbA1) as an objective measure of long-term blood glucose control in diabetic children.
- To compare the efficacy of HbA1 measurements with traditional methods of assessing glycemic control.
- To investigate the relationship between HbA1 levels and growth parameters in pediatric diabetes patients.
Main Methods:
- Measurement of total glycosylated hemoglobin (HbA1) levels in 94 diabetic children aged 3–19 years.
- Comparison of HbA1 results with home urine glucose testing and 24-hour urine glucose excretion.
- Correlation analysis of HbA1 levels with height velocity and other growth indicators.
Main Results:
- HbA1 levels demonstrated significant correlations with home urine glucose testing (P<0.05), 24-hour urine glucose excretion (P<0.01), and height velocity (P<0.001).
- Traditional methods showed considerable variability, suggesting lower accuracy for assessing glycemic control.
- Elevated HbA1 levels were associated with reduced height velocity (less than 10th centile), indicating a negative impact of poor glycemic control on growth.
Conclusions:
- Total glycosylated hemoglobin (HbA1) provides a more objective assessment of long-term glycemic control in diabetic children compared to traditional methods.
- HbA1 measurement is a valuable tool for monitoring diabetes management and understanding its impact on growth.
- Further research can explore the role of HbA1 in predicting and preventing long-term diabetic complications through optimized glycemic control.
Abstract:
Total glycosylated haemoglobin (HbA1) levels were measured in 94 diabetic children aged between 3 and 19 years. The results were compared with traditional methods of assessing blood glucose control. HbA1 levels correlated with home urine glucose testing (P less than 0.05), with 24-hour urine glucose excretion (P less than 0.01), and with height velocity (P less than 0.001). Within the first two of these parameters there was a wide scatter of results, suggesting the inaccuracy of these methods for assessing control. The association of raised HbA1 levels with height velocities less than 10th centile shows the effect of poor control on growth. HbA1 may prove to be an objective method for assessing long-term blood glucose levels in diabetes, and thus it may be possible to determine the effect of good control in the prevention of the various diabetic complications.